Evidence map›Paper›PMID 33407442›Full record

ArticleBMC health services research2021

Leveraging gains from African Center for Integrated Laboratory Training to combat HIV epidemic in sub-Saharan Africa.

Ritu Shrivastava, Richard Poxon, Erin Rottinghaus, Leyya Essop, Victoria Sanon, Zawadi Chipeta, Elsie van-Schalkwyk, Phuti Sekwadi, Pelagia Murangandi, Shon Nguyen and 10 more

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Ritu ShrivastavaInternational Laboratory Branch (ILB), Division of Global HIV and TB (DGHT), Centres for Disease Control and Prevention (CDC), 1600 Clifton Road NE, Atlanta, GA, 30333, USA. zni4@cdc.gov.ORCID http://orcid.org/0000-0002-8954-2214
Richard PoxonAfrican Center for Integrated Laboratory Training at National Health Laboratory Service, Johannesburg, South Africa.
Erin RottinghausInternational Laboratory Branch (ILB), Division of Global HIV and TB (DGHT), Centres for Disease Control and Prevention (CDC), 1600 Clifton Road NE, Atlanta, GA, 30333, USA.
Leyya EssopAfrican Center for Integrated Laboratory Training at National Health Laboratory Service, Johannesburg, South Africa.
Victoria SanonGeorgia State University, intern at ILB, DGHT, CDC, Atlanta, USA.
Zawadi ChipetaLaboratory Branch, DGHT, CDC, Pretoria, South Africa.
Elsie van-SchalkwykAfrican Center for Integrated Laboratory Training at National Health Laboratory Service, Johannesburg, South Africa.
Phuti SekwadiAfrican Center for Integrated Laboratory Training at National Health Laboratory Service, Johannesburg, South Africa.
Pelagia MurangandiAfrican Center for Integrated Laboratory Training at National Health Laboratory Service, Johannesburg, South Africa.
Shon NguyenInternational Laboratory Branch (ILB), Division of Global HIV and TB (DGHT), Centres for Disease Control and Prevention (CDC), 1600 Clifton Road NE, Atlanta, GA, 30333, USA.
Josh DevosInternational Laboratory Branch (ILB), Division of Global HIV and TB (DGHT), Centres for Disease Control and Prevention (CDC), 1600 Clifton Road NE, Atlanta, GA, 30333, USA.
Shanna Nesby-OdellInternational Laboratory Branch (ILB), Division of Global HIV and TB (DGHT), Centres for Disease Control and Prevention (CDC), 1600 Clifton Road NE, Atlanta, GA, 30333, USA.
Thomas StevensInternational Laboratory Branch (ILB), Division of Global HIV and TB (DGHT), Centres for Disease Control and Prevention (CDC), 1600 Clifton Road NE, Atlanta, GA, 30333, USA.
Farouk UmaruSupply Chain Management System, United States Agency for Internationl Development, Atlanta, USA.
Alex CoxDGHT, CDC, Atlanta, USA.
Andrea KimDGHT, CDC, Atlanta, USA.
Chunfu YangInternational Laboratory Branch (ILB), Division of Global HIV and TB (DGHT), Centres for Disease Control and Prevention (CDC), 1600 Clifton Road NE, Atlanta, GA, 30333, USA.
Linda M ParsonsInternational Laboratory Branch (ILB), Division of Global HIV and TB (DGHT), Centres for Disease Control and Prevention (CDC), 1600 Clifton Road NE, Atlanta, GA, 30333, USA.
Babatyi Malope-KgokongAfrican Center for Integrated Laboratory Training at National Health Laboratory Service, Johannesburg, South Africa.
John N NkengasongInternational Laboratory Branch (ILB), Division of Global HIV and TB (DGHT), Centres for Disease Control and Prevention (CDC), 1600 Clifton Road NE, Atlanta, GA, 30333, USA.
Centers for Disease Control and Prevention · USNational Health Laboratory Service · ZACDC Foundation · USGeorgia State University · USUnited States Agency for International Development · US

Funding

Center for Global Health, Office of the Associate Director for Science/Laboratory Science CGH HSR Tracking Number 2015-010National Health Laboratory Services U2GPS001328 and NU2GGH001631NCHHSTP CDC HHS U2G PS001328
6 · The paper itself

Abstract

backgroundIn sub-Saharan Africa, there is dearth of trained laboratorians and strengthened laboratory systems to provide adequate and quality laboratory services for enhanced HIV control. In response to this challenge, in 2007, the African Centre for Integrated Laboratory Training (ACILT) was established in South Africa with a mission to train staffs from countries with high burdens of diseases in skills needed to strengthen sustainable laboratory systems. This study was undertaken to assess the transference of newly gained knowledge and skills to other laboratory staff, and to identify enabling and obstructive factors to their implementation.

methodsWe used Kirkpatrick model to determine training effectiveness by assessing the transference of newly gained knowledge and skills to participant's work environment, along with measuring enabling and obstructive factors. In addition to regular course evaluations at ACILT (pre and post training), in 2015 we sent e-questionnaires to 867 participants in 43 countries for course participation between 2008 and 2014. Diagnostics courses included Viral Load, and systems strengthening included strategic planning and Biosafety and Biosecurity. SAS v9.44 and Excel were used to analyze retrospective de-identified data collected at six months pre and post-training.

resultsOf the 867 participants, 203 (23.4%) responded and reported average improvements in accuracy and timeliness in Viral Load programs and to systems strengthening. For Viral Load testing, frequency of corrective action for unsatisfactory proficiency scores improved from 57 to 91%, testing error rates reduced from 12.9% to 4.9%; 88% responders contributed to the first national strategic plan development and 91% developed strategies to mitigate biosafety risks in their institutions. Key enabling factors were team and management support, and key obstructive factors included insufficient resources and staff's resistance to change.

conclusionsTraining at ACILT had a documented positive impact on strengthening the laboratory capacity and laboratory workforce and substantial cost savings. ACILT's investment produced a multiplier effect whereby national laboratory systems, personnel and leadership reaped training benefits. This laboratory training centre with a global clientele contributed to improve existing laboratory services, systems and networks for the HIV epidemic and is now being leveraged for COVID-19 testing that has infected 41,332,899 people globally.

Indexed as

Africa South of the SaharaClinical Laboratory ServicesCOVID-19 TestingEpidemicsHealth Services ResearchHIV InfectionsHIV TestingHumansLaboratoriesLaboratory PersonnelRetrospective StudiesHealth worker trainingKirkpatrick modelLaboratory system strengtheningLeverageQuality of testingTraining assessmentTraining effectiveness

Identifiers

PMID33407442
PMCPMC7787229
OpenAlexW3121090873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.